Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Survival

From: Modular tumor endoprostheses in surgical palliation of long-bone metastases: a reduction in tumor burden and a durable reconstruction

  Mean 1 year survival rate 5 year survival rate
All patients 35 months 70% 20%
Renal cell 38 months 72% 25%
Breast 44 months 87% 27%
Lung 22 months 67% 0%
Solitary bone late onset 49 months 91% 29%
All others 33 months 67% 18%
Revision surgery 53 months   
No revision surgery 30 months